OpenURL Connection Search

Select item for more details and to access through your institution.

Prognostic Parameters for Response to Enzalutamide After Docetaxel and Abiraterone Treatment in Metastatic Castration-Resistant Prostate Cancer Patients; a Possible Time Relation.
Published in:
Prostate, 2016, v. 76, n. 1, p. 32, doi. 10.1002/pros.23094
By:
- Badrising, Sushil K.;
- van der Noort, Vincent;
- van den Eertwegh, Alfons J.M.;
- Hamberg, Paul;
- van Oort, Inge M.;
- van den Berg, Hendrik P.;
- Los, Maartje;
- Aarts, Maureen J.B.;
- Coenen, Jules L.L.M.;
- Gelderblom, Hans;
- de Jong, Igle J.;
- Kerver, Emile D.;
- Vrijaldenhoven, Suzan;
- van Voorthuizen, Theo;
- Warmerdam, Fabienne;
- Haanen, John B.;
- Bergman, Andries M.
Publication type:
Article
Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.
Published in:
Prostate, 2009, v. 69, n. 10, p. 1101, doi. 10.1002/pros.20957
By:
- Ananias, Hildo J.K.;
- van den Heuvel, Marius C.;
- Helfrich, Wijnand;
- de Jong, Igle J.
Publication type:
Article
Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal Fibrosis.
Published in:
Pharmaceutics, 2020, v. 12, n. 5, p. 459, doi. 10.3390/pharmaceutics12050459
By:
- Bigaeva, Emilia;
- Puerta Cavanzo, Nataly;
- Stribos, Elisabeth G. D.;
- de Jong, Amos J.;
- Biel, Carin;
- Mutsaers, Henricus A. M.;
- Jensen, Michael S.;
- Nørregaard, Rikke;
- Leliveld, Anna M.;
- de Jong, Igle J.;
- Hillebrands, Jan-Luuk;
- van Goor, Harry;
- Boersema, Miriam;
- Bank, Ruud A.;
- Olinga, Peter
Publication type:
Article
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.
Published in:
Oncology, 2016, v. 91, n. 5, p. 267, doi. 10.1159/000448219
By:
- Badrising, Sushil K.;
- van der Noort, Vincent;
- Hamberg, Paul;
- Coenen, Jules L.L.M.;
- aarts, Maureen J.;
- van Oort, Inge M.;
- van den Eertwegh, alfons J.M.;
- Los, Maartje;
- van den Berg, H. Pieter;
- Gelderblom, Hans;
- Vrijaldenhoven, Suzan;
- Kerver, Emile D.;
- van Voorthuizen, Theo;
- de Jong, Igle J.;
- Haanen, John B.;
- Bergman, andries M.
Publication type:
Article
Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment.
Published in:
Cancers, 2021, v. 13, n. 22, p. 5675, doi. 10.3390/cancers13225675
By:
- Stelwagen, Johannes;
- Meuleman, Andrea T.;
- Lubberts, Sjoukje;
- Steursma, Gerrie;
- Kruyt, Lara M.;
- Donkerbroek, Jan W.;
- Meijer, Coby;
- Walenkamp, Annemiek M. E.;
- Lefrandt, Joop D.;
- Rakers, Sandra E.;
- Huitema, Rients B.;
- de Jong, Marianne A. A.;
- Wiegman, Erwin M.;
- van den Bergh, Alfons C. M.;
- de Jong, Igle J.;
- van Rentergem, Joost A. Agelink;
- Schagen, Sanne B.;
- Nuver, Janine;
- Gietema, Jourik A.
Publication type:
Article
Tc-HDP bone scintigraphy and F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer.
Published in:
World Journal of Urology, 2018, v. 36, n. 1, p. 27, doi. 10.1007/s00345-017-2096-3
By:
- Wondergem, Maurits;
- van der Zant, Friso M.;
- Knol, Remco J. J.;
- Burgers, Anne Marij G.;
- Bos, Siebe D.;
- de Jong, Igle J.;
- Pruim, Jan
Publication type:
Article
Treatment and outcome in muscle invasive bladder cancer: a population-based survey.
Published in:
World Journal of Urology, 2010, v. 28, n. 4, p. 439, doi. 10.1007/s00345-010-0546-2
By:
- Leliveld, Anna M.;
- Doornweerd, Benjamin H. J.;
- Bastiaannet, Esther;
- Schaapveld, Michael;
- de Jong, Igle J.
Publication type:
Article
Platinum exposure and cause-specific mortality among patients with testicular cancer.
Published in:
2019
By:
- Groot, Harmke J;
- van Leeuwen, Flora E;
- Lubberts, Sjoukje;
- Horenblas, Simon;
- de Wit, Ronald;
- Witjes, J Alfred;
- Groenewegen, Gerard;
- Poortmans, Philip M;
- Hulshof, Maarten C C M;
- Meijer, Otto W M;
- de Jong, Igle J;
- van den Berg, Hetty A;
- Smilde, Tineke J;
- Vanneste, Ben G L;
- Aarts, Maureen J B;
- Jóźwiak, Katarzyna;
- van den Belt-Dusebout, Alexandra W;
- Gietema, Jourik A;
- Schaapveld, Michael
Publication type:
journal article
Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.
Published in:
Cancer (0008543X), 2014, v. 120, n. 7, p. 968, doi. 10.1002/cncr.28518
By:
- Badrising, Sushil;
- van der Noort, Vincent;
- van Oort, Inge M.;
- van den Berg, H. Pieter;
- Los, Maartje;
- Hamberg, Paul;
- Coenen, Jules L.;
- van den Eertwegh, Alfons J. M.;
- de Jong, Igle J.;
- Kerver, Emile D.;
- van Tinteren, Harm;
- Bergman, Andries M.
Publication type:
Article
In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2005, v. 32, n. 6, p. 668, doi. 10.1007/s00259-004-1741-4
By:
- Breeuwsma, Anthonius J.;
- Pruim, Jan;
- Jongen, Maud M.;
- Suurmeijer, Albert J.;
- Vaalburg, Wim;
- Nijman, Rien J.;
- de Jong, Igle J.
Publication type:
Article
Visualisation of bladder cancer using [sup 11] C-choline PET: first clinical experience.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2002, v. 29, n. 10, p. 1283, doi. 10.1007/s00259-002-0881-7
By:
- de Jong, Igle J.;
- Pruim, Jan;
- Elsinga, Philip H.;
- Jongen, Maud J.;
- Mensink, Han A.;
- Vaalburg, Willem
Publication type:
Article
Response to: Fu-Xiang Lin, Yi Yu, Zhan-Ping Xu Letter to Editor: Unveiling the Crystal Clear: Cone Beam Computed Tomography's Role in Enhancing PCNL Outcomes and the Path Forward.
Published in:
Journal of Endourology, 2024, v. 38, n. 11, p. e1241, doi. 10.1089/end.2024.0452
By:
- Altobelli, Emanuela;
- Kingma, Riemer;
- Mors, Rianne;
- Bus, Mieke T.J.;
- de Jong, Igle J.;
- Roemeling, Stijn
Publication type:
Article
Does Computed Tomography or Positron Emission Tomography/Computed Tomography Contribute to Detection of Small Focal Cancers in the Prostate?
Published in:
Journal of Endourology, 2010, v. 24, n. 5, p. 693, doi. 10.1089/end.2009.0470
By:
- Li, Michael M.;
- Rybalov, Maxim;
- Haider, Masoom A.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- Waarde, Aren van;
- O Dierckx, Rudi A. J.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, W.;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 29, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
18F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and Biodistribution.
Published in:
Journal of Nuclear Medicine, 2017, v. 58, n. 11, p. 1797, doi. 10.2967/jnumed.117.192658
By:
- Wondergem, Maurits;
- van der Zant, Friso M.;
- Knol, Remco J. J.;
- Lazarenko, Sergiy V.;
- Pruim, Jan;
- de Jong, Igle J.
Publication type:
Article
89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.
Published in:
Journal of Nuclear Medicine, 2017, v. 58, n. 6, p. 905, doi. 10.2967/jnumed.116.183475
By:
- van Es, Suzanne C.;
- Brouwers, Adrienne H.;
- Mahesh, Shekar V. K.;
- Leliveld-Kors, Annemarie M.;
- de Jong, Igle J.;
- Lub-de Hooge, Marjolijn N.;
- de Vries, Elizabeth G. E.;
- Gietema, Jourik A.;
- Oosting, Sjoukje F.
Publication type:
Article
Molecular Imaging of Prostate Cancer: Tapping into the Opportunities.
Published in:
Journal of Nuclear Medicine, 2015, v. 56, n. 2, p. 169, doi. 10.2967/jnumed.114.150219
By:
- Oyen, Wim J. G.;
- De Jong, Igle J.
Publication type:
Article
89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.
Published in:
Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 63, doi. 10.2967/jnumed.114.144840
By:
- Oosting, Sjoukje F.;
- Brouwers, Adrienne H.;
- van Es, Suzanne C.;
- Nagengast, Wouter B.;
- Munnink, Thijs H. Oude;
- Lub-de Hooge, Marjolijn N.;
- Hollema, Harry;
- de Jong, Johan R.;
- de Jong, Igle J.;
- de Haas, Sanne;
- Scherer, Stefan J.;
- Sluiter, Wim J.;
- Dierckx, Rudi A.;
- Bongaerts, Alfons H. H.;
- Gietema, Jourik A.;
- de Vries, Elisabeth G. E.
Publication type:
Article
Preoperative Staging of Pelvic Lymph Nodes in Prostate Cancer by 11C-Choline PET.
Published in:
Journal of Nuclear Medicine, 2003, v. 44, n. 3, p. 331
By:
- De Jong, Igle J.;
- Pruim, Jan;
- Elsinga, Philip H.;
- Vaalburg, Willem;
- Mensink, Han J.
Publication type:
Article
Compliance with biopsy recommendations of a prostate cancer risk calculator.
Published in:
BJU International, 2012, v. 109, n. 10, p. 1480, doi. 10.1111/j.1464-410X.2011.10611.x
By:
- van Vugt, Heidi A.;
- Roobol, Monique J.;
- Busstra, Martijn;
- Kil, Paul;
- Oomens, Eric H.;
- de Jong, Igle J.;
- Bangma, Chris H.;
- Steyerberg, Ewout W.;
- Korfage, Ida
Publication type:
Article
EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study.
Published in:
International Journal of Molecular Sciences, 2017, v. 18, n. 8, p. 1802, doi. 10.3390/ijms18081802
By:
- van der Fels, Christa A. M.;
- Rosati, Stefano;
- de Jong, Igle J.
Publication type:
Article
EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study.
Published in:
International Journal of Molecular Sciences, 2016, v. 17, n. 10, p. 1650, doi. 10.3390/ijms17101650
By:
- Campos, Anna K.;
- Hoving, Hilde D.;
- Rosati, Stefano;
- van Leenders, Geert J. L. H.;
- de Jong, Igle J.
Publication type:
Article
PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy.
Published in:
International Journal of Molecular Sciences, 2014, v. 15, n. 4, p. 6046, doi. 10.3390/ijms15046046
By:
- Rybalov, Maxim;
- Ananias, Hildo J. K.;
- Hoving, Hilde D.;
- van der Poel, Henk G.;
- Rosati, Stefano;
- de Jong, Igle J.
Publication type:
Article

Found: 31

Prognostic Parameters for Response to Enzalutamide After Docetaxel and Abiraterone Treatment in Metastatic Castration-Resistant Prostate Cancer Patients; a Possible Time Relation.

Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.

Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal Fibrosis.

Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.

Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment.

Tc-HDP bone scintigraphy and F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer.

Treatment and outcome in muscle invasive bladder cancer: a population-based survey.

Platinum exposure and cause-specific mortality among patients with testicular cancer.

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.

In vivo uptake of [<sup>11</sup>C]choline does not correlate with cell proliferation in human prostate cancer.

Visualisation of bladder cancer using [sup 11] C-choline PET: first clinical experience.

Response to: Fu-Xiang Lin, Yi Yu, Zhan-Ping Xu Letter to Editor: Unveiling the Crystal Clear: Cone Beam Computed Tomography's Role in Enhancing PCNL Outcomes and the Path Forward.

Does Computed Tomography or Positron Emission Tomography/Computed Tomography Contribute to Detection of Small Focal Cancers in the Prostate?

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

<sup>18</sup>F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and Biodistribution.

<sup>89</sup>Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.

Molecular Imaging of Prostate Cancer: Tapping into the Opportunities.

<sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.

Preoperative Staging of Pelvic Lymph Nodes in Prostate Cancer by <sup>11</sup>C-Choline PET.

Compliance with biopsy recommendations of a prostate cancer risk calculator.

EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study.

EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study.

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy.